Cargando…
Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy
PURPOSE: Orbital fibroblasts are now recognized as the key effectors in the development of thyroid associated ophthalmopathy (TAO). TAO is clinically apparent in approximately 50% of patients with Graves’ hyperthyroidism. High levels of plasma free fatty acids (FFAs) are frequently seen in patients...
Autores principales: | Paik, Ji-Sun, Cho, Won-Kyung, Oh, Eun-Hye, Lee, Seong-Beom, Yang, Suk-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380905/ https://www.ncbi.nlm.nih.gov/pubmed/22736938 |
Ejemplares similares
-
The Effect of (-)-Epigallocatechin-3-Gallate on IL-1β Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy
por: Lee, Ji-Young, et al.
Publicado: (2016) -
Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-κB pathway
por: Kim, Sung Eun, et al.
Publicado: (2021) -
Effect of Orbital Decompression on Corneal Topography in Patients with Thyroid Ophthalmopathy
por: Kim, Su Ah, et al.
Publicado: (2015) -
IL-11 Is Elevated and Drives the Profibrotic Phenotype Transition of Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy
por: Wu, Pengsen, et al.
Publicado: (2022) -
MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy
por: Bo-ding, Tong, et al.
Publicado: (2015)